Madrigal is focused on developing therapeutics to improve the lives of patients with metabolic and fatty liver diseases.
Liver Disease • NASH • Metabolic Disease
51 - 200
💰 $259M Post-IPO Equity on 2022-12
April 25
Madrigal is focused on developing therapeutics to improve the lives of patients with metabolic and fatty liver diseases.
Liver Disease • NASH • Metabolic Disease
51 - 200
💰 $259M Post-IPO Equity on 2022-12
• Provide primary legal support for public company reporting and SEC compliance • Provide advice regarding securities law disclosure/compliance • Provide legal advice and counseling with respect to equity-based compensation plans
• Juris Doctorate and admission to a state bar (or eligibility for in-house counsel admission) • 8-12 years legal experience across life science companies and large law firms • Demonstrated expertise in corporate governance matters and SEC compliance required
• Provide primary legal support for public company reporting and SEC compliance • Provide advice regarding securities law disclosure/compliance • Provide legal advice and counseling with respect to equity-based compensation plans
Apply Now